# The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry

> **NCT02843412** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Gastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue Blocks

## Interventions

- **PROCEDURE:** choose two tumor tissue paraffin blocks

## Key facts

- **NCT ID:** NCT02843412
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-05
- **Final completion:** —
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02843412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02843412, "The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using Immunohistochemistry". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02843412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*